ACE2 expression significantly affects prognosis in four types of cancers, including KIRC, brain lower grade glioma (LGG), LIHC, and ovarian serous cystadenocarcinoma (OV) (Figure S1). The gene discussed is ACE2; the disease is ovarian serous cystadenocarcinoma.